These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1631251)

  • 61. Prolactin response to the dopamine antagonists sulpiride and domperidone. Further evidence for pituitary dopamine deficiency in hyperprolactinemic disorders of different etiology.
    Ferrari C; Scarduelli C; Rampini P; Brambilla G; Benco R; Pistolesi E; Paracchi A; Mattei A; Boghen M; Crosignani PG
    Gynecol Obstet Invest; 1983; 16(5):299-306. PubMed ID: 6642291
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma prolactin concentration and psychopathology of schizophrenia.
    Otani K; Kondo T; Ishida M; Tanaka O; Yasui N; Suzuki A; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Nov; 20(8):1369-74. PubMed ID: 9004343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prolactin stimulating effects of amoxapine and loxapine in psychiatric patients.
    Robertson AG; Berry R; Meltzer HY
    Psychopharmacology (Berl); 1982; 78(3):287-92. PubMed ID: 6818584
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Specialties of prolactin secretion and peripheral reproductive sex hormones in patients with of first episode of schizophrenia].
    Gorobets LN; Matrosova MI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):17-22. PubMed ID: 21183909
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Studies on the central and peripheral dopaminergic control of PRL secretion in man: failure to demonstrate the existence of a dopamine-mediated prolactin-inhibiting factor.
    Ho KY; Smythe GA; Lazarus L
    Neuroendocrinology; 1985 Jun; 40(6):457-62. PubMed ID: 3925361
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms.
    Jones H; Curtis VA; Wright P; Lucey JV
    Am J Psychiatry; 1998 Jun; 155(6):838-40. PubMed ID: 9619161
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition.
    Pohl CR; Weiner RI; Smith MS
    Endocrinology; 1988 Sep; 123(3):1591-7. PubMed ID: 3402398
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of domperidone on serum prolactin levels in human beings.
    Fujino T; Kato H; Yamashita S; Aramaki S; Morioka H; Koresawa M; Miyauchi F; Toyoshima H; Torigoe T
    Endocrinol Jpn; 1980 Aug; 27(4):521-5. PubMed ID: 7460861
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
    Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects.
    Wodarz N; Fritze J; Riederer P; Beckmann H
    Biol Psychiatry; 1993 May; 33(10):727-33. PubMed ID: 8353168
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disparate effects of acute administration of dopamine receptor antagonists on plasma aldosterone and prolactin levels in the rat.
    Van der Niepen P; Dupont AG; Buydens P; Smitz JJ; Vanhaelst L
    Horm Metab Res; 1987 Jun; 19(6):279-80. PubMed ID: 3305273
    [No Abstract]   [Full Text] [Related]  

  • 76. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia.
    Albayrak Y; Beyazyüz M; Beyazyüz E; Kuloğlu M
    Nord J Psychiatry; 2014 Jul; 68(5):341-6. PubMed ID: 24094029
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hormones, dopamine receptors and schizophrenia.
    Meltzer HY; Busch D; Fang VS
    Psychoneuroendocrinology; 1981; 6(1):17-36. PubMed ID: 7244055
    [No Abstract]   [Full Text] [Related]  

  • 79. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):7-16. PubMed ID: 3928213
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of prolactin responses to D-1 and D-2 antagonists in rats: Ro 22-1319 is a potent D-2 antagonist.
    Kaneda H; Shintani T; Kakigi T; Terada T; Tanimoto K
    Biol Psychiatry; 1989 Feb; 25(4):517-22. PubMed ID: 2564788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.